Arnold J.R., McCann G.P. (2020) Cardiovascular Mag-
netic Resonance: Applications and Practical Considerations for the
General Cardiologist. Heart, Vol. 106(3): 174–181. doi: 10.1136/
heartjnl-2019–314856.
11.
Aquaro G.D., Habtemicael G.Y., Camastra G. et al. (2019)
Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients
With Acute Myocarditis. J. Am. Coll. Cardiol., Vol. 74(20): 2439–2448.
DOI: 10.1016/j.jacc.2019.08.1061.
12.
Beling A., Kespohl M. (2018) Proteasomal Protein Degrada-
tion: Adaptation of Cellular Proteolysis With Impact on Virus-and Cyto-
kine-Mediated Damage of Heart Tissue During Myocarditis. Front Immu-
nol., Vol. 9: 2620. doi: 10.3389/fimmu.2018.02620.
13.
Bettencourt N. (2019) Cardiac Magnetic Resonance in Myocar-
ditis — Do We Need More Tools? Rev. Port. Cardiol., Vol. 38(11): 777–
778. doi: 10.1016/j.repc.2020.01.002.
14.
Błyszczuk P. (2019) Myocarditis in Humans and in Experimen-
tal Animal Models. Front Cardiovasc Med., Vol. 6: 64. doi: 10.3389/
fcvm.2019.00064.
15.
Blauwet L.A., Cooper L.T. (2016) Myocarditis. Prog. Cardio-
vasc. Dis., Vol. 52(4): 274–88. DOI: 10.1016/j.pcad.2009.11.006.
16.
Caforio A.L.P., Adler Y., Agostini C. et al. (2017) Diag-
nosis and management of myocardial involvement in systemic im-
mune-mediated diseases: a position statement of the European Soci-
ety of Cardiology Working Group on Myocardial and Pericardial Disease.
Eur. Heart J., Vol. 38(35): 2649–2662. doi: 10.1093/eurheartj/ehx321.
PMID: 28655210.
17.
Caforio A.L., Malipiero G., Marcolongo R. et al. (2017)
Myocarditis: a clinical overview. Curr. Cardiol. Rep., Vol. 19(7): 63. doi:
10.1007/s11886–017–0870-x.
18.
